Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Effects of inosine on reperfusion injury after cardiopulmonary bypass.

Veres G, Radovits T, Seres L, Horkay F, Karck M, Szabó G.

J Cardiothorac Surg. 2010 Nov 8;5:106. doi: 10.1186/1749-8090-5-106.

2.

Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.

Szabó G, Seres L, Soós P, Gorenflo M, Merkely B, Horkay F, Karck M, Radovits T.

Eur J Cardiothorac Surg. 2011 Sep;40(3):695-700. doi: 10.1016/j.ejcts.2010.12.033. Epub 2011 Feb 15.

PMID:
21324707
3.

Effects of inosine on reperfusion injury after heart transplantation.

Szabó G, Stumpf N, Radovits T, Sonnenberg K, Gerö D, Hagl S, Szabó C, Bährle S.

Eur J Cardiothorac Surg. 2006 Jul;30(1):96-102. Epub 2006 May 26.

PMID:
16730445
4.

Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.

Szabó G, Buhmann V, Andrási T, Stumpf N, Bährle S, Kékesi V, Hagl S, Szabó C, Juhász-Nagy A.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):651-8.

PMID:
14502135
5.

Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass.

Radovits T, Beller CJ, Groves JT, Merkely B, Karck M, Szabó C, Szabó G.

Eur J Cardiothorac Surg. 2012 Feb;41(2):391-6. doi: 10.1016/j.ejcts.2011.05.056.

6.

Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.

Szabó G, Radovits T, Veres G, Krieger N, Loganathan S, Sandner P, Karck M.

Eur J Cardiothorac Surg. 2009 Oct;36(4):657-64. doi: 10.1016/j.ejcts.2009.03.065. Epub 2009 Jun 11.

PMID:
19523842
7.

Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass.

Veres G, Radovits T, Otila G, Hirschberg K, Haider H, Krieger N, Knoll A, Weigang E, Szabolcs Z, Karck M, Szabó G.

Thorac Cardiovasc Surg. 2010 Mar;58(2):86-92. doi: 10.1055/s-0029-1186271. Epub 2010 Mar 23.

PMID:
20333570
8.

INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.

Szabó G, Soós P, Mandera S, Heger U, Flechtenmacher C, Bährle S, Seres L, Cziráki A, Gries A, Zsengellér Z, Vahl CF, Hagl S, Szabó C.

Shock. 2004 May;21(5):426-32.

PMID:
15087818
9.

Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5'-diphosphate-ribose) polymerase.

Szabó G, Soós P, Mandera S, Heger U, Flechtenmacher C, Seres L, Zsengellér Z, Sack FU, Szabó C, Hagl S.

Crit Care Med. 2004 Dec;32(12):2392-7.

PMID:
15599141
10.

L-arginine: effect on reperfusion injury after heart transplantation.

Szabó G, Bährle S, Bátkai S, Stumpf N, Dengler TJ, Zimmermann R, Vahl CF, Hagl S.

World J Surg. 1998 Aug;22(8):791-7; discussion 797-8.

PMID:
9673548
11.

Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.

Szabó G, Soós P, Bährle S, Zsengellér Z, Flechtenmacher C, Hagl S, Szabó C.

Eur J Cardiothorac Surg. 2004 May;25(5):825-32.

PMID:
15082289
12.

Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.

Radovits T, Korkmaz S, Miesel-Gröschel C, Seidel B, Stasch JP, Merkely B, Karck M, Szabó G.

Eur J Cardiothorac Surg. 2011 Feb;39(2):248-55. doi: 10.1016/j.ejcts.2010.05.025. Epub 2010 Jun 29.

PMID:
20591683
13.

Sodium/hydrogen-exchanger inhibition during cardioplegic arrest and cardiopulmonary bypass: an experimental study.

Cox CS Jr, Sauer H, Allen SJ, Buja LM, Laine GA.

J Thorac Cardiovasc Surg. 2002 May;123(5):959-66.

14.

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.

Veres G, Radovits T, Merkely B, Karck M, Szabó G.

J Cardiothorac Surg. 2015 Feb 28;10:27. doi: 10.1186/s13019-015-0226-9.

15.

The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest.

Fischer UM, Cox CS Jr, Allen SJ, Stewart RH, Mehlhorn U, Laine GA.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1483-8.

16.

Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.

Allen BS, Veluz JS, Buckberg GD, Aeberhard E, Ignarro LJ.

J Thorac Cardiovasc Surg. 2003 Mar;125(3):625-32.

17.

Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest.

Ogino H, Smolenski RT, Zych M, Seymour AM, Yacoub MH.

Ann Thorac Surg. 1996 Aug;62(2):469-74.

PMID:
8694607
18.

Cardioprotective effects of hydrogen sulfide.

Szabó G, Veres G, Radovits T, Gero D, Módis K, Miesel-Gröschel C, Horkay F, Karck M, Szabó C.

Nitric Oxide. 2011 Aug 1;25(2):201-10. doi: 10.1016/j.niox.2010.11.001. Epub 2010 Nov 19.

19.

Sialyl lewis oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs.

Schermerhorn ML, Tofukuji M, Khoury PR, Phillips L, Hickey PR, Sellke FW, Mayer JE Jr, Nelson DP.

J Thorac Cardiovasc Surg. 2000 Aug;120(2):230-7.

20.

Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass.

Jormalainen M, Vento AE, Lukkarinen H, Kääpä P, Kytö V, Lauronen J, Paavonen T, Suojaranta-Ylinen R, Petäjä J.

J Cardiothorac Vasc Anesth. 2007 Apr;21(2):224-31. Epub 2006 May 30.

PMID:
17418736

Supplemental Content

Support Center